1973
DOI: 10.1128/jvi.11.4.552-564.1973
|View full text |Cite
|
Sign up to set email alerts
|

New Intermediate Subviral Particles in the In Vitro Uncoating of Reovirus Virions by Chymotrypsin

Abstract: Reovirus virions, grown in suspension cultures of L cells and extensively purified by density gradient and velocity gradient centrifugation after their release from cell debris by fluorocarbon extraction, are characterized by a mean particle diameter of 73 nm and a density in CsCl of 1.36 to 1.37 g/cm 3 . Treatment of intact virions by chymotrypsin (CHT) digestion in vitro converts them to subviral particles (SVP) having characteristics which are determined by the species of monovalent … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
51
1

Year Published

1974
1974
2019
2019

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(53 citation statements)
references
References 27 publications
1
51
1
Order By: Relevance
“…Analogous to furin-mediated priming of many class I viral fusion proteins, CatL-mediated cleavage of the Nipah paramyxovirus glycoprotein precursor, F 0 , to F 1 plus F 2 occurs in virus producer cells, liberating an N-terminal fusion peptide in F 2 and sensitizing F for fusion triggering (48). Like EBOV GP, the nonenveloped mammalian reovirus capsid undergoes extensive proteolytic disassembly during entry; 600 copies of the 3 protector protein are degraded by CatL and CatB to expose the 1 penetration protein (8,17,19). Unlike the EBOV GP 17K intermediate, the Nipah virus and reovirus intermediates no longer require cysteine protease activity to enter cells (1,13,57).…”
Section: Vol 84 2010mentioning
confidence: 99%
“…Analogous to furin-mediated priming of many class I viral fusion proteins, CatL-mediated cleavage of the Nipah paramyxovirus glycoprotein precursor, F 0 , to F 1 plus F 2 occurs in virus producer cells, liberating an N-terminal fusion peptide in F 2 and sensitizing F for fusion triggering (48). Like EBOV GP, the nonenveloped mammalian reovirus capsid undergoes extensive proteolytic disassembly during entry; 600 copies of the 3 protector protein are degraded by CatL and CatB to expose the 1 penetration protein (8,17,19). Unlike the EBOV GP 17K intermediate, the Nipah virus and reovirus intermediates no longer require cysteine protease activity to enter cells (1,13,57).…”
Section: Vol 84 2010mentioning
confidence: 99%
“…T1L, T1L/T3D M2, T1L μ1 M258I, T1L σ3 S344P, T1L μ1 M258I σ3 S344P, or T1L/T3D M2 μ1 M258I σ3 S344P virions (2×10 12 particles/ml) were digested with 200 μg/ml TLCK ( N α- p -tosyl-L-lysine chloromethyl ketone)-treated chymotrypsin (Worthington Biochemical) in a total volume of 100 μl for 20 min at 32°C (30, 31). The reactions were then incubated on ice for 20 min and quenched by the addition of 1 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma-Aldrich).…”
Section: Methodsmentioning
confidence: 99%
“…2A) (29). The resulting intermediate is called the infectious subviral particle (30). Proteolytic disassembly (virion-to-ISVP conversion) is recapitulated in vitro by treating purified virions with exogenous protease (2931).…”
Section: Introductionmentioning
confidence: 99%
“…T1L, T1L/T3D M2, T1L/T3D M2 μ1 E89A, or T1L/T3D M2 μ1 D371A virions (2×10 12 particles/ml) were digested with 200 μg/ml TLCK ( N α- p -tosyl-L-lysine chloromethyl ketone)-treated chymotrypsin (Worthington Biochemical) in a total volume of 100 μl for 20 min at 32°C (36, 37). The reactions were then incubated on ice for 20 min and quenched by the addition of 1 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma-Aldrich).…”
Section: Methodsmentioning
confidence: 99%